Δημοσιεύσεις

Κατάλογος ενδεικτικών δημοσιεύσεων του τμήματος Ιατρικής ΑΠΘ σε διεθνή επιστημονικά περιοδικά κατά τα τελευταία 5 έτη.

Export 34 results:
Συντάκτης Τίτλος Τύπος [ Έτος(Asc)]
Φίλτρα: Συντάκτης is Papademetriou, Vasilios  [Clear All Filters]
2019
Stavropoulos, K., Imprialos K. P., Faselis C., Karagiannis A., & Papademetriou V. (2019).  Determinants of pulse wave velocity index and potential implementations.. J Clin Hypertens (Greenwich).
Stavropoulos, K., Imprialos K. P., Doumas M., Karagiannis A., & Papademetriou V. (2019).  Insomnia and hypertension: A misty landscape.. J Clin Hypertens (Greenwich). 21(6), 835-837.
2018
Doumas, M., Katsiki N., & Papademetriou V. (2018).  Psoriasis and Cardiovascular Disease: Two Sides of the Same Coin?. Angiology. 69(1), 5-9.
2017
Papademetriou, V., Nylen E. S., Doumas M., Probstfield J., Mann J. F. E., Gilbert R. E., et al. (2017).  Chronic Kidney Disease, Basal Insulin Glargine, and Health Outcomes in People with Dysglycemia: The ORIGIN Study.. Am J Med. 130(12), 1465.e27-1465.e39.
Bress, A. P., King J. B., Kreider K. E., Beddhu S., Simmons D. L., Cheung A. K., et al. (2017).  Effect of Intensive Versus Standard Blood Pressure Treatment According to Baseline Prediabetes Status: A Post Hoc Analysis of a Randomized Trial.. Diabetes Care.
Vogiatzakis, N., Tsioufis C., Georgiopoulos G., Thomopoulos C., Dimitriadis K., Kasiakogias A., et al. (2017).  Effect of renal sympathetic denervation on short-term blood pressure variability in resistant hypertension: a meta-analysis.. J Hypertens. 35(9), 1750-1757.
Papademetriou, V., Lovato L., Tsioufis C., Cushman W., Applegate W. B., Mottle A., et al. (2017).  Effects of High Density Lipoprotein Raising Therapies on Cardiovascular Outcomes in Patients with Type 2 Diabetes Mellitus, with or without Renal Impairment: The Action to Control Cardiovascular Risk in Diabetes Study.. Am J Nephrol. 45(2), 136-145.
Tsioufis, C., Iliakis P., Kasiakogias A., Konstantinidis D., Lovic D., Petras D., et al. (2017).  Non-pharmacological Modulation of the Autonomic Nervous System for Heart Failure Treatment: Where do We Stand?. Curr Vasc Pharmacol. 16(1), 30-43.
Tsioufis, C., Dimitriadis K., Kordalis A., Doumas M., Konstantinidis D., Kalos T., et al. (2017).  Renal Denervation Therapy: Can it Contribute to Better Blood Pressure Control in Hypertension?. Curr Vasc Pharmacol. 16(1), 66-69.
Raman, V. K., Tsioufis C., Doumas M., & Papademetriou V. (2017).  Renal Denervation Therapy for Drug-Resistant Hypertension: Does It Still Work?. Curr Treat Options Cardiovasc Med. 19(5), 39.
Doumas, M., Tsioufis C., Fletcher R., Amdur R., Faselis C., & Papademetriou V. (2017).  Time in Therapeutic Range, as a Determinant of All-Cause Mortality in Patients With Hypertension.. J Am Heart Assoc. 6(11), 
2016
Stergiou, G. S., Doumas M., Kollias A., & Papademetriou V. (2016).  Important practice lessons from the SPRINT study beyond the blood pressure goal: all well known and now confirmed.. J Am Soc Hypertens. 10(8), 613-7.
Papademetriou, V., Doumas M., & Tsioufis C. (2016).  Renal Sympathetic Denervation: Hibernation or Resurrection?. Cardiology. 135(2), 87-97.
2015
Doumas, M., Papademetriou V., Athyros V., & Karagiannis A. (2015).  Arterial Stiffness and Emerging Biomarkers: Still a Long Journey to Go.. Angiology. 66(10), 901-3.
Doumas, M., Athyros V., & Papademetriou V. (2015).  Screening for Primary Aldosteronism: Whom and How?. J Clin Hypertens (Greenwich). 17(7), 547-8.
2014
Tsioufis, C., Kasiakogias A., Kordalis A., Dimitriadis K., Thomopoulos C., Tsiachris D., et al. (2014).  Dynamic resistant hypertension patterns as predictors of cardiovascular morbidity: a 4-year prospective study.. J Hypertens. 32(2), 415-22.
Doumas, M., Tsioufis C., Faselis C., Lazaridis A., Grassos H., & Papademetriou V. (2014).  Non-interventional management of resistant hypertension.. World J Cardiol. 6(10), 1080-90.
Tsioufis, C., Dimitriadis K., Thomopoulos C., Doumas M., Papademetriou V., & Stefanadis C. (2014).  Renal and cardiac effects of renal sympathetic denervation and carotid baroreceptor stimulation.. Curr Vasc Pharmacol. 12(1), 55-62.
Papademetriou, V., Tsioufis C., & Doumas M. (2014).  Renal denervation and Symplicity HTN-3: "Dubium sapientiae initium" (doubt is the beginning of wisdom).. Circ Res. 115(2), 211-4.
Papademetriou, V., Rashidi A. Adel, Tsioufis C., & Doumas M. (2014).  Renal nerve ablation for resistant hypertension: how did we get here, present status, and future directions.. Circulation. 129(13), 1440-51.
Doumas, M., Lazaridis A., & Papademetriou V. (2014).  Renal nerve ablation for resistant hypertension: the dust has not yet settled.. J Clin Hypertens (Greenwich). 16(6), 399-400.
Kokkinos, P., Faselis C., Myers J., Kokkinos J. Peter, Doumas M., Pittaras A., et al. (2014).  Statin therapy, fitness, and mortality risk in middle-aged hypertensive male veterans.. Am J Hypertens. 27(3), 422-30.
2013
Doumas, M., Papademetriou V., Faselis C., & Kokkinos P. (2013).  Gender differences in hypertension: myths and reality.. Curr Hypertens Rep. 15(4), 321-30.
2011
Papademetriou, V., Doumas M., Faselis C., Tsioufis C., Douma S., Gkaliagkousi E., et al. (2011).  Carotid baroreceptor stimulation for the treatment of resistant hypertension.. Int J Hypertens. 2011, 964394.
Papademetriou, V., Doumas M., & Tsioufis K. (2011).  Renal Sympathetic Denervation for the Treatment of Difficult-to-Control or Resistant Hypertension.. Int J Hypertens. 2011, 196518.

Σελίδες

Επικοινωνία

Τμήμα Ιατρικής, Πανεπιστημιούπολη ΑΠΘ, T.K. 54124, Θεσσαλονίκη
 

Συνδεθείτε

Το τμήμα Ιατρικής στα κοινωνικά δίκτυα.
Ακολουθήστε μας ή συνδεθείτε μαζί μας.

           

Σύνδεσμοι

 

Το πανεπιστήμιο

 
 

Προσωπικό & Φοιτητές